MedTrace Logo

Comparing the Effects of Different Doses of Dexamethasone to Treat Inpatient COVID-19

NCT04707534 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2024-03-29

Study results available
· View outcomes & findings →

Summary

This open label clinical trial is to evaluate two different doses of dexamethasone on the health outcome using World Health Organization ordinal scale at day 28 in hospitalized patients with COVID-19.

Conditions

  • Covid19

Interventions

DRUG

Dexamethasone

Dexamethasone

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Huimin Wu, MD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-21
Primary Completion
2021-12-31
Completion
2022-03-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04707534 on ClinicalTrials.gov